Early post-bevacizumab change in rCBV from DSC-MRI identifies pseudoresponse in recurrent glioblastoma: Results from ACRIN 6677/RTOG 0625 is a research paper published in Frontiers in Oncology (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: U10 CA180794
NCI NIH HHS
Grant: R01 CA264992
NCI NIH HHS
Grant: U10 CA180820
National Institutes of Health
Grant: 5R01CA255123-04
New treatment monitoring biomarkers for brain tumors using multiparametric MRI with machine learning
National Institutes of Health
Grant: 5U01CA176110-03
Quantitative (Perfusion and Diffusion) MRI Biomarkers to Measure Glioma Response
National Institutes of Health
Grant: 1R01CA221938-01
Multi-site Validation and Application of a Consensus DSC MRI Protocol
National Institutes of Health
Grant: 5U01CA079778-11
Biostatistics Data Management Center for ACRIN
National Institutes of Health
Grant: 3U01CA080098-12S1
American College of Radiology Imaging Network
National Institutes of Health
Grant: 3U10CA180820-02S3
ECOG-ACRIN Operations Center
National Institutes of Health
Grant: 5U10CA180794-04
ECOG-ACRIN Network Group Statistics and Data Management Center
National Institutes of Health
Grant: 5R01CA264992-03
Establishing the clinical utility of a consensus DSC-MRI Protocol
FWCI
1.15
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals